Annual report for Jubilant Life Sciences Ltd. for FY-2015
12-05-2015
Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Jubilant Life Sciences Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
GA Global Investments Ltd has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011Funds' buying may boost Jubilant Life
East Bridge Cap MTR Fund and Morgan Stanley (Singapore) each bought 60 lakh shares and 27.29 lakh shares of Jubilant Lifesciences on Tuesday, according to NSE bulk deal data. They bought t...FY15 results on May 12, 2015
Jubilant Life Sciences Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 12, 2015, inter-alia to consider:1. Audited Financial Results of the Company for the year ended March 31,2015,2. Recommendation of Dividend for the year ended March 31, 2015.Further, as per the Companys Insider Trading Code, the trading window for dealing in the securities of the Company would remain closed...Shareholding Pattern For March 31, 2015
Jubilant Life Sciences Ltd has informed BSE about the Shareholding Pattern as on March 31, 2015.Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Jubilant Life Sciences Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
GA Global Investments Ltd has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011Disclosure of Voting results of Postal Ballot (Clause 35A)
Jubilant Life Sciences Ltd has informed BSE regarding the details of voting results of Postal Ballot, under Clause 35A.Result of Postal Ballot
Jubilant Life Sciences Ltd has informed BSE that the members of the Company have passed the resolution, by way of Postal Ballot.